MedPath

国药集团同济堂(贵州)制药有限公司

Ownership
-
Established
2005-06-29
Employees
-
Market Cap
-
Website
www.tjtzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

150

NMPA:150

Drug Approvals

Acetylspiramycin Capsules

Product Name
乙酰螺旋霉素胶囊
Approval Number
国药准字H52020661
Approval Date
Apr 23, 2021
NMPA

Glucurolactone Tablets

Product Name
葡醛内酯片
Approval Number
国药准字H52020188
Approval Date
Aug 12, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H52020013
Approval Date
Aug 12, 2020
NMPA

Bifendate Tablets

Product Name
联苯双酯片
Approval Number
国药准字H52020613
Approval Date
Aug 10, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H52020020
Approval Date
Aug 10, 2020
NMPA

Pediatric Compound Sulfamethoxazole Tablets

Product Name
小儿复方磺胺甲噁唑片
Approval Number
国药准字H52020660
Approval Date
Aug 10, 2020
NMPA

Ethambutol Hydrochloride Tablets

Product Name
盐酸乙胺丁醇片
Approval Number
国药准字H52020005
Approval Date
Aug 10, 2020
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H52020022
Approval Date
Aug 10, 2020
NMPA

复方元胡止痛片

Approval Number
国药准字Z20063186
Approval Date
Aug 10, 2020
NMPA

Glucurolactone Tablets

Product Name
葡醛内酯片
Approval Number
国药准字H52020120
Approval Date
Aug 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.